Ritux doesn’t work for ME/CFS as far as we know.Thought I'd bump this closer to the top of the pile now that the eMSN connection has surfaced:
Thread on "Three cases with chronic obsessive compulsive disorder report gains in wellbeing and function following rituximab treatment, 2024, Gallwitz et al"
Thread on "Rituximab for psychosis (double-blind RCT protocol)"
Comment by the second team on the works of the first team ("Three cases with chronic obsessive compulsive disorder report gains in wellbeing and function following rituximab treatment, 2024, Gallwitz et al")
Sorry if that's already been brought to attention elsewhere. There are some very honest comments in the thread on the quality of the scientific reasoning in the second paper. The data points might suddenly have become very interesting though.
Indeed! Was more alluding to the general idea of immune system involvement in some cases of these two diseases, since they possibly share a connection with ME through specific cell types.Ritux doesn’t work for ME/CFS as far as we know.
I'm not on any stimulant but I do feel like whenever I'm stimulated I get less symptoms and feel like I'm able to do more without getting PEM. Now whether that's due to dopamine, adrenaline, cortisol or other neurotransmitters I do not know.Even after years of this, I am always a little surprised by the range of symptoms my vyvanse dose reduces (which then return when it wears off). Flu-y symptoms, muscle aches, cognitive problems I have with fine motor skills and shakiness. I guess maybe this isn't too surprising because stimulants can reduce feelings/symptoms of sickness in other contexts too (e.g. the stimulant decongestant Pseudoephedrine can make people feel less flu-y when they have the flu). I wish we understood how this was happening though!
This is super interesting to me. My mom has had severe migraines for most of her life. Tried all the treatments and nothing worked. Until CGRP inhibitors.. she hasn't had a single episode since. Another disease that's been woefully underfunded. But on a more positive note it shows what can happen once targeted research happens and a drug gets developed that directly targets the disease-specific biology.With migraine, the breakthrough was made when they took blood from the external jugular vein during a migraine attack and found high levels of CGRP. Interestingly this doesn't show up if you take blood from the body. I wonder if it would be worth doing this for pwME/CFS during PEM to see if anything showed up.
The researchers then infused CGRP into migraine patients and healthy controls and found it triggered an attack in the migraine patients but the healthy controls only had a mild headache.
Whenever I suggest that researchers try something similar (something that might make PWME temporarily worse) to identify reliable factors, it gets shot down because "researchers aren't allowed to do anything that might cause even temporary harm". I think it would be very helpful to learn that Interleukin-whichever reliably makes symptoms worse in 87% of PWME, or whatever. I'm guessing that the migraine study used levels that were normally encountered in humans, which seems to be the case in ME, since no one has found dramatically elevated levels of anything.The researchers then infused CGRP into migraine patients and healthy controls and found it triggered an attack in the migraine patients but the healthy controls only had a mild headache.